These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9790899)

  • 21. Splicing Mutations Impairing CDKL5 Expression and Activity Can be Efficiently Rescued by U1snRNA-Based Therapy.
    Balestra D; Giorgio D; Bizzotto M; Fazzari M; Ben Zeev B; Pinotti M; Landsberger N; Frasca A
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A putative exonic splicing enhancer in exon 7 of the PDHA1 gene affects splicing of adjacent exons.
    Ridout CK; Keighley P; Krywawych S; Brown RM; Brown GK
    Hum Mutat; 2008 Mar; 29(3):451. PubMed ID: 18273899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of splice sites on the intron retention in histamine H3 receptors from rats and mice.
    Ding W; Lin L; Ren F; Zou H; Duan Z; Dai J
    J Genet Genomics; 2009 Aug; 36(8):475-82. PubMed ID: 19683670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro.
    Thi Tran HT; Takeshima Y; Surono A; Yagi M; Wada H; Matsuo M
    Mol Genet Metab; 2005 Jul; 85(3):213-9. PubMed ID: 15979033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of serum albumin levels in nagase analbuminemic rats by hepatocyte transplantation.
    Oren R; Dabeva MD; Petkov PM; Hurston E; Laconi E; Shafritz DA
    Hepatology; 1999 Jan; 29(1):75-81. PubMed ID: 9862853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upstream region of rat serum albumin gene promoter contributes to promoter activity: presence of functional binding site for hepatocyte nuclear factor-3.
    Hsiang CH; Marten NW; Straus DS
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):241-9. PubMed ID: 10024498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
    Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy.
    Scalet D; Balestra D; Rohban S; Bovolenta M; Perrone D; Bernardi F; Campaner S; Pinotti M
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):15-20. PubMed ID: 27639833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease-causing variants of the conserved +2T of 5' splice sites can be rescued by engineered U1snRNAs.
    Scalet D; Maestri I; Branchini A; Bernardi F; Pinotti M; Balestra D
    Hum Mutat; 2019 Jan; 40(1):48-52. PubMed ID: 30408273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional analysis of a new splice site mutation, c.605-3C>A, in the cystinuria gene SLC7A9 leading to exon skipping.
    Schmidt C; Lahme S; Zerres K; Eggermann T
    Mol Genet Metab; 2005 Feb; 84(2):172-5. PubMed ID: 15670723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 5' splice site enhances the recruitment of basal transcription initiation factors in vivo.
    Damgaard CK; Kahns S; Lykke-Andersen S; Nielsen AL; Jensen TH; Kjems J
    Mol Cell; 2008 Feb; 29(2):271-8. PubMed ID: 18243121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel splicing mutation causes analbuminemia in a Portuguese boy.
    Caridi G; Dagnino M; Di Duca M; Pinto H; Espinheira Mdo C; Guerra A; Fernandes S; Campagnoli M; Galliano M; Minchiotti L
    Mol Genet Metab; 2012 Mar; 105(3):479-83. PubMed ID: 22227324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of intravenous methotrexate in mutant Nagase analbuminemic rats.
    Choi YH; Bae SK; Oh JM; Kim SO; Lee MG
    Biopharm Drug Dispos; 2007 Oct; 28(7):385-92. PubMed ID: 17657787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. U1-like snRNAs lacking complementarity to canonical 5' splice sites.
    Kyriakopoulou C; Larsson P; Liu L; Schuster J; Söderbom F; Kirsebom LA; Virtanen A
    RNA; 2006 Sep; 12(9):1603-11. PubMed ID: 16829670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping.
    Goyenvalle A; Vulin A; Fougerousse F; Leturcq F; Kaplan JC; Garcia L; Danos O
    Science; 2004 Dec; 306(5702):1796-9. PubMed ID: 15528407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hypercapnia on BP in hypoalbuminemic and Nagase analbuminemic rats.
    Gómez JL; Gunnerson KJ; Song M; Li J; Kellum JA
    Chest; 2007 May; 131(5):1295-300. PubMed ID: 17494780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced glomerular permeability to macromolecules in the Nagase analbuminemic rat.
    Fujihara CK; Arcos-Fajardo M; Brandão De Almeida Prado E; José Brandão De Almeida Prado M; Sesso A; Zatz R
    Am J Physiol Renal Physiol; 2002 Jan; 282(1):F45-50. PubMed ID: 11739111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on analbuminemic rats.
    Nagase S
    Prog Clin Biol Res; 1987; 229():27-34. PubMed ID: 3601988
    [No Abstract]   [Full Text] [Related]  

  • 40. Analbuminemia produced by a novel splicing mutation.
    Dolcini L; Caridi G; Dagnino M; Sala A; Gökçe S; Sökücü S; Campagnoli M; Galliano M; Minchiotti L
    Clin Chem; 2007 Aug; 53(8):1549-52. PubMed ID: 17644793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.